Leucadia Therapeutics Inc Company
Leucadia Therapeutics Inc is privately-held, pre-clinical stage company focused on Alzheimer's disease prevention and treatment. The company is developing a diagnostic algorithm for Alzheimer's disease risk based on big data. A therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. (alzheimers Alzheimers alzheimer's neurodegeneration)
Technology:
Big Data, Biotechnology, Health Diagnostics, Life Science, Medical Device, Neuroscience
Industry:
Early Drug Development, Preclinical Development
Headquarters:
Riverside, California, United States
Founded Date:
2015-10-29
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
1
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-06-25
Last Funding Type:
Seed
Register and Claim Ownership